Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anrikefon vs Nalfurafine for Sleep Quality in CKD-aP Patients on Hemodialysis
NCT07380113Phase 4Recruiting
- Sponsor
- Southern Medical University Zhujiang Hospital
- Start
- Jun 2026
- Primary completion
- Dec 2027
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of hsk21542 in chronic kidney disease (CKD), sponsored by Southern Medical University Zhujiang Hospital. Started Jun 2026; status: recruiting.
02
Drugs
hsk21542
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT07380113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07380113.